Migraine is a growing public health concern in India. According to a study published in The Journal of Headache and Pain, nearly 26.3% of people in Delhi NCR suffer from the condition. Pfizer on ...

Drug maker Pfizer on Monday said it has launched a new medication for migraine treatment. The company has introduced Rimegepant ODT in India for adults with a previous insufficient response to triptan ...

Global pharmaceutical company Pfizer has announced the launch of a Rimegepant Orally Disintegrating Tablet (ODT) in India for acute treatment of migraine in adults with a previous insufficient ...

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...

Pfizer launches new migraine drug in India (Image Source: Freepik) Drug maker Pfizer on Monday introduced a new migraine treatment in India, offering hope to millions who struggle with severe and ...

US drugmaker Pfizer has brought its Rimegepant (Orally Disintegrating Tablet -ODT) to India, to treat acute migraine, in adults with a previous insufficient response to triptan. “The new medication ...

https://www.thehindubusinessline.com/companies/pfizer-launches-new-medication-for-migraine-treatment/article70290052.ece Copy Drug maker Pfizer on Monday said it has ...

PHOENIX -- A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn't shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce ...

Lead author Sowmya Ramesh, Ph.D., a postdoctoral researcher in pathology at the Johns Hopkins University School of Medicine, explains that the two medications, already approved by the USFDA for ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pfizer Inc. is conducting a Phase 3 ...

A specialist headache service in Sussex has been described as "revolutionary" following the introduction of new drugs specifically to target migraine. The service at University Hospitals Sussex ...